KemPharm Inc (KMPH) Insider Trading
Total insider buys:
- $9,037,415.66
Total insider sells:
- $0.00
Most recent insider trade:
- Jan. 13, 2023
Most active insider trader:
- R. Laduane Clifton
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 13, 2023 | CFO | 635 | $5.81 | Buy | $3,689.35 | |
| Jan. 13, 2023 | CEO | 9,500 | $5.44 | Buy | $51,680.00 | |
| Sept. 30, 2022 | CFO | 1,000 | $5.98 | Buy | $5,980.00 | |
| May 25, 2022 | Director | 2,000 | $4.39 | Buy | $8,780.00 | |
| May 25, 2022 | CEO | 3,000 | $4.37 | Buy | $13,110.00 | |
| May 20, 2022 | Director | 200 | $4.87 | Buy | $974.00 | |
| May 18, 2022 | CFO | 1,200 | $5.00 | Buy | $6,000.00 | |
| May 18, 2022 | Chairman | 5,000 | $4.92 | Buy | $24,600.00 | |
| Nov. 30, 2021 | Chairman | 1,500 | $7.88 | Buy | $11,820.00 | |
| Nov. 30, 2021 | Director | 2,000 | $7.79 | Buy | $15,580.00 | |
| Nov. 18, 2021 | CEO | 2,250 | $8.23 | Buy | $18,517.50 | |
| Nov. 18, 2021 | CFO | 510 | $8.29 | Buy | $4,227.90 | |
| Sept. 29, 2021 | CFO | 215 | $9.38 | Buy | $2,016.70 | |
| Sept. 20, 2021 | CFO | 935 | $8.59 | Buy | $8,031.65 | |
| Sept. 1, 2021 | CFO | 230 | $9.11 | Buy | $2,095.30 | |
| Aug. 30, 2021 | CEO | 5,000 | $8.92 | Buy | $44,600.00 | |
| June 23, 2021 | CFO | 75 | $14.11 | Buy | $1,058.25 | |
| May 27, 2021 | CFO | 150 | $9.85 | Buy | $1,477.50 | |
| May 13, 2021 | Major Shareholder | 10,000 | $8.55 | Buy | $85,500.00 | |
| Aug. 26, 2020 | CFO | 1,000 | $0.84 | Buy | $840.00 | |
| Aug. 18, 2020 | CFO | 2,000 | $0.70 | Buy | $1,400.00 | |
| Aug. 18, 2020 | Director | 10,000 | $0.64 | Buy | $6,400.00 | |
| June 11, 2020 | CFO | 1,500 | $0.19 | Buy | $285.00 | |
| June 2, 2020 | CEO | 110,000 | $0.18 | Buy | $19,800.00 | |
| May 26, 2020 | CFO | 11,500 | $0.19 | Buy | $2,185.00 | |
| March 25, 2020 | CFO | 1,000 | $0.22 | Buy | $220.00 | |
| March 13, 2020 | VP | 4,000 | $0.20 | Buy | $800.00 | |
| March 11, 2020 | CFO | 8,000 | $0.25 | Buy | $2,000.00 | |
| March 9, 2020 | VP | 333 | $0.25 | Buy | $83.25 | |
| March 5, 2020 | CEO | 25,000 | $0.31 | Buy | $7,750.00 | |
| Dec. 31, 2019 | Insider | 20,000 | $0.41 | Buy | $8,200.00 | |
| Dec. 27, 2019 | CFO | 12,250 | $0.42 | Buy | $5,145.00 | |
| Sept. 25, 2019 | CFO | 3,650 | $0.75 | Buy | $2,737.50 | |
| Sept. 24, 2019 | CEO | 50,000 | $0.79 | Buy | $39,500.00 | |
| Sept. 24, 2019 | VP | 3,000 | $0.74 | Buy | $2,220.00 | |
| Sept. 16, 2019 | CFO | 5,000 | $0.89 | Buy | $4,450.00 | |
| Sept. 11, 2019 | CFO | 500 | $0.95 | Buy | $475.00 | |
| Sept. 9, 2019 | Insider | 10,000 | $0.82 | Buy | $8,200.00 | |
| Sept. 6, 2019 | CFO | 850 | $0.77 | Buy | $654.50 | |
| Oct. 12, 2018 | Insider | 1,000 | $2.61 | Buy | $2,610.00 | |
| Oct. 12, 2018 | VP | 3,000 | $2.53 | Buy | $7,590.00 | |
| Oct. 12, 2018 | CEO | 5,000 | $2.55 | Buy | $12,750.00 | |
| Oct. 11, 2018 | CFO | 650 | $2.54 | Buy | $1,651.00 | |
| Oct. 10, 2018 | Insider | 3,000 | $2.62 | Buy | $7,860.00 | |
| Oct. 5, 2018 | Major Shareholder | 2,000,000 | $3.00 | Buy | $6,000,000.00 | |
| July 30, 2018 | Major Shareholder | 304,283 | $4.00 | Buy | $1,217,132.00 | |
| May 31, 2018 | CFO | 525 | $6.10 | Buy | $3,202.50 | |
| May 15, 2018 | EVP | 7,900 | $6.45 | Buy | $50,955.00 | |
| Nov. 27, 2017 | EVP | 7,500 | $3.79 | Buy | $28,425.00 | |
| Sept. 25, 2017 | CFO | 300 | $3.78 | Buy | $1,134.00 |
Insiders are buying KemPharm Inc stock.
The insider traders at KemPharm Inc are: R. Laduane Clifton, Travis C Mickle, Daniel L Cohen, Gordon K Johnson, Timothy J Sangiovanni, Richard W Pascoe, Delaware Street Capital Master, David S Tierney, Tamara A Seymour, and Samuel J. Braun
The most active insider trader at KemPharm Inc is R. Laduane Clifton with 25 trades.
Delaware Street Capital Master has bought the most KemPharm Inc stock with a total value of $14,282,785.76.
The most recent insider trade for KemPharm Inc was on Jan. 13, 2023.
The single biggest insider buy for KemPharm Inc was from Delaware Street Capital Master with a total value of $6,000,000.00 on Oct. 5, 2018.